Health Condition 1: J849- Interstitial pulmonary disease, unspecified
Conditions
Interventions
Intervention1: TAB BENZONATATE 100 MG TDS COMPAIRED WITH SYP LEVODROPROPIZINE 10ML TDS: TAB BENZONATATE 100 MG TDS COMPAIRED WITH SYP LEVODROPROPIZINE FOR TREATMENT OF CHRONIC REFRACTORY COUGH IN ILD
Sponsors
Dr Naveen Dutt
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age 18 year and older 2.Consenting to participate in the study 3.Radiologically or histopathologically diagnosed ILD 4.Those with chronic refractory cough 5.Patient taking same baseline treatment for ILD for last 2 weeks
Exclusion criteria
Exclusion criteria: 1.Cognitively impaired patient 2.Pregnant or lactating female 3.Not willing to participate in study 4.Severely ill patients 5.Known hypersensitivity to local anesthetic 6.Other treatable causes of cough 7. Active smoker 8.Already taking cough medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy of Benzonatate and Levodropropizine in treatment of chronic refractory cough in ILD Patients using Leicester Cough QuestionnaireTimepoint: 2 Week and 4 week | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To assess the efficacy of Benzonatate & Levodropropizine in symptomatic relief of chronic refractory cough in ILD Patients using cough VAS score. 2. To check the safety profile of Benzonatate & Levodropropizine therapy. 3. To identify the factors affecting the outcome of therapy Timepoint: 2 week & 4 week | — |
Countries
India
Contacts
Public ContactDr Naveen Dutt
AIIMS Jodhpur
Outcome results
None listed